CoaguChek® INRange system
CoaguChek INRange is the new connected self-testing meter that gives you the freedom to test your PT/INR at home, on the go, or wherever you happen to be.
Its Bluetooth® technology allows you to wirelessly transmit PT/INR results to your healthcare provider, so you can be confident you are in your target therapeutic range and in control.
Choose peace of mind
By engaging in your own therapy through self-monitoring, you can spend more time in your target therapeutic range (TTR)1 and less time in the clinic1,2. The CoaguChek INRange system makes it easy.
Ask your healthcare professional about self-monitoring with the CoaguChek INRange system to:
More time in therapeutic range
Spend more time in therapeutic range and less time waiting for appointments
Test anywhere, anytime
It is easy to use and takes just a small drop of blood for virtually pain-free testing
Immediate results at your fingertips
Results in less than a minute. You'll know you're in range and on track
Choose freedom of monitoring
on your own terms.
Discover self-testing with the
CoaguChek® INRange System.
Choose confidence in the CoaguChek INRange which offers more information than just your PT/INR result. With trending reports, comments and color coded graphs, you can quickly see your results, and how it relates to recent activity.
Results trend reporting
The CoaguChek INRange meter will let you know if your most recent result is higher or lower than your last result to help you understand if you are trending.
Bluetooth or USB connectivity
Connect your meter using Bluetooth or USB to quickly and easily send results to your healthcare professional. For more information about compatible software for data transfer with the CoaguChek INRange meter please contact your local Roche Diagnostics customer support.
The color display makes important information such as color coded results noticeable so that they are easy to read and understand.
Target range aware
The meter enables you to track your time in range by graphically displaying how many times you have been within, above or below your target therapeutic range.
Enter up to 6 comments with each result to help you remember what is happening in your life that may have affected the result.
Reminders and on screen help
You can set reminders for when to test or take medication directly on your meter.
On-screen help provides text guidance through the test procedure.
- CoaguChek INRange meter
- CoaguChek XS Softclix lancing device - for single patient use only
- CoaguChek Softclix lancets (bag of 10)
- Carrying case
- User's Manual
- Quick Reference Guide
- USB cable
- 4 x AAA batteries
Additional required components:
- CoaguChek XS PT Test PST strips (in a vial)
CoaguChek INRange system handling video
- Measuring & Sampling
Amperometric (electrochemical) determination of the PT time after activation of the coagulation with human recombinant thromboplastin
Intuitive user interface with color display, on/off, enter, back and up/down button
Outside the meter top- and 2 sides: left or right,-dosing options
- Operating Conditions
+ 15° C to + 32° C (59° F to 90° F)
10 - 85%
4300 m (14,000 ft)
- First option: Operate the monitor on a level surface, free of vibrations
- Second option: Hold the monitor in your hand, so that it is roughly horizontal
Measuring range INR
0.8 - 8.0
USB (Type B) and Bluetooth
Battery - Four 1.5v AAA alkali-manganese batteries
# of tests per set of batteries
Up to 60 tests or 1 year
145 x 75 x 30 mm
135 g (without batteries)
400 Test Results
Auto Power Off
Auto off after 2 minutes of inactivity
- Sample Material
Fresh capillary whole blood
Refer to the test-strip package insert.
- Test Strips
Sensitivity to heparin
Not at therapeutic levels, up to 0.8 I.U/ml for UFH and to 2 anti-Xa U/ml for LMWH
On each strip, through the same channel as the blood passes
21 months from production (+ 2° C to + 30° C)
Display of target range
1. Heneghan C, Ward A, Perera R, et al. (2012). Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet379:322-334.
2. Sharma, P., Scotland, G., Cruickshank, M., Tassie, E., Fraser, C., et al (2015). Is self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluation. BMJ Open 5:e007758